| |
|
|
|
Citius Pharmaceuticals Inc.  
|
|
1.12 -0.05 (-0.04%) |
02-19 16:00 |
|
Open: |
1.18 |
Pre close: |
1.17 |
Target:
|
1.40
|
|
High: |
1.2 |
Low: |
1.0216 |
Resistance:
|
1.20
1.40
|
|
Volume: |
249,126 |
Market Cap: |
21M |
Support:
|
0.99
0.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.04
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.01  |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
1.28 |
Stochastic Oscillator |
%K(14,3):
|
82.39 |
|
MA(250): |
2.00 |
%D(3): |
64.03 |
|
Average Volume(K) |
3-Month: |
13103
|
52-Week |
High:
|
3.80 |
|
10-Days: |
18517 |
Low: |
0.86 |
|
RSI |
RSI(14):
|
56.88 |
Change(%): |
-70.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-50.3 |
Shares Out. (M) |
17.80 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.2 |
Shares Float (M) |
9.58 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
77.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.60 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.580 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.04 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.64 |
P/CF |
-1.81 |
|
|
|
|
|
|
